Pharmacologically inducing anoikis offers novel therapeutic opportunities in hepatocellular carcinoma
Open Access
- 5 June 2024
- journal article
- review article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 176, 116878
Abstract
No abstract availableKeywords
This publication has 108 references indexed in Scilit:
- Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapyMedcomm, 2024
- Matrine suppresses hepatocellular carcinoma tumorigenesis by modulating circ_0055976/miR‐1179/lactate dehydrogenase A axisEnvironmental Toxicology, 2023
- Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implicationsMedcomm, 2023
- Understanding and targeting anoikis in metastasis for cancer therapiesCell Biology International, 2022
- Noncoding RNAs in tumor metastasis: molecular and clinical perspectivesCellular and Molecular Life Sciences, 2021
- Targeting molecular signal transduction pathways in hepatocellular carcinoma and its implications for cancer therapyCell Biology International, 2021
- Astrocyte elevated gene 1 (AEG‐1) promotes anoikis resistance and metastasis by inducing autophagy in hepatocellular carcinomaJournal of Cellular Physiology, 2019
- OLFM4 Enhances STAT3 Activation and Promotes Tumor Progression by Inhibiting GRIM19 Expression in Human Hepatocellular CarcinomaHepatology Communications, 2019
- 17β‐Estradiol inhibits testosterone‐induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptorJournal of Cellular Biochemistry, 2018
- Anoikis: an emerging hallmark in health and diseasesThe Journal of Pathology, 2011